BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12065769)

  • 1. [125I]2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a high-affinity radioligand selective for I1 imidazoline receptors.
    Greney H; Urosevic D; Schann S; Dupuy L; Bruban V; Ehrhardt JD; Bousquet P; Dontenwill M
    Mol Pharmacol; 2002 Jul; 62(1):181-91. PubMed ID: 12065769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptors.
    Urosevic D; Schann S; Ehrhardt JD; Bousquet P; Greney H
    Br J Pharmacol; 2004 Jun; 142(3):609-17. PubMed ID: 15178642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.
    Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.
    Velliquette RA; Ernsberger P
    J Pharmacol Exp Ther; 2003 Aug; 306(2):646-57. PubMed ID: 12756274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
    Piletz JE; Zhu H; Chikkala DN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites.
    Molderings GJ; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1995 May; 351(5):507-16. PubMed ID: 7643914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
    Ernsberger P; Friedman JE; Koletsky RJ
    J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR; King PR; Louis WJ; Gundlach AL
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
    Velliquette RA; Kossover R; Previs SF; Ernsberger P
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):300-12. PubMed ID: 16416266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells.
    Rustenbeck I; Herrmann C; Ratzka P; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):410-7. PubMed ID: 9303581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands.
    Anastassiadou M; Danoun S; Crane L; Baziard-Mouysset G; Payard M; Caignard DH; Rettori MC; Renard P
    Bioorg Med Chem; 2001 Mar; 9(3):585-92. PubMed ID: 11310592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein.
    Li F; Wu N; Su RB; Zheng JQ; Xu B; Lu XQ; Cong B; Li J
    J Cell Biochem; 2006 Aug; 98(6):1615-28. PubMed ID: 16598778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors.
    Dontenwill M; Vonthron C; Greney H; Magnier C; Heemskerk F; Bousquet P
    Ann N Y Acad Sci; 1999 Jun; 881():123-34. PubMed ID: 10415908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of platelet α2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses.
    Hikasa Y; Masuda K; Asakura Y; Yamashita Y; Sato C; Kamio M; Miura A; Taniguchi T; Minamizuru N
    Eur J Pharmacol; 2013 Nov; 720(1-3):363-75. PubMed ID: 24120658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid body I1-imidazoline receptors: binding, visualization and modulatory function.
    Ernsberger P; Kou YR; Prabhakar NR
    Respir Physiol; 1998 Jun; 112(3):239-51. PubMed ID: 9749948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling.
    Musgrave IF; Hughes RA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.